Patent

Peer to Patent Project: Democratising Patent Review


Calling for a ‘Vox Populi’ on the review of Patent applications, a pilot project , the ‘Peer to Patent Project’ has been launched by Beth Noveck of the New York Law School Institute of Information Law and Policy. Structured on the lines of a deliberative internet based model that encourages community participation in the review of patent applications, it paves the way for a paradigm shift from the traditional process of patent application review and grant. Excerpts from the article…


Read More »

Price Controls in India: Emerging Dichotomy between Consumers Groups and Domestic Industry


The ET reports on the recent opposition of the pharmaceutical industry to price controls: “Pharma industry on Wednesday opposed a move to tighten controls on drug pricing at a meeting of a Group of Ministers, even as Chemicals Minister Ram Vilas Paswan maintained his stand for expanding the list of essential medicines to be regulated. “My ministry is in favour of strengthening National Pharmaceutical Pricing Authority (NPPA) so that prices of essential medicines remain under check,” Paswan reporters after the…


Read More »
Innovation

SpicyIP Tidbits


1. Minister gets Innovative, announces Indian Innovation Act: CNN-IBN reports that Kapil Sibal, the Minister of Science and Technology is promoting an Indian Innovation Act. I quote: “In an effort to increase research investment, the Science and Technology Ministry has announced the Indian Innovation Act. It has asked FICCI to prepare a draft for the act by December this year. The aim of the legislation would be not just to increase research investment, but also strengthen education opportunities in science,…


Read More »
Copyright

Living in Glass Houses… (Cont.)


I have been getting a number of comments and suggestions from all around on the last piracy post – this is really inspiring, and very informative! As promised, here’s a summary of all the comments and suggestions received so far for the benefit of all our readers… please keep them coming! Price cuts and Per feature Pricing Ravi suggests that software companies can help themselves a great deal by allowing customers to choose the features that they want and pay…


Read More »

SpicyIP Events


1. National Seminar on Patents on 23rd September,2007. Thanks to Malavika Kumar, an outstanding student at ILS, Pune for bringing this to our attention. This workshop is organised by the Indian Institute of e Business Management(IIeBM)in association with GMGC and Times Group and will include discussions on a wide variety of India IP themes, including the Novartis Case, Software Patenting and E-filing of Patents Prominent speakers include Dr. Raghunath Mashelkar (Former Director General of CISR,India) and Dr. S. Chandrashekaran (Former…


Read More »
Others

Need Co-Bloggers


If any of you are interested in joining SpicyIP as a co-blogger, please let me know ([email protected]). We are particularly interested in folks that can blog on non patent related IP matters (copyright, trademarks, traditional knowledge, GI’s) or even “innovation” more generally or any other IP/innovation theme that has some relevance for India. The understanding between us now is that each blogger post at least once a week. We intend to make this blog a one stop shop for leading…


Read More »

SpicyIP Events


1. NAS Conference on Innovation in India and China: For details on this upcoming conference by the National Academy of Sciences (NAS) in Washington DC (Sept 24-25), please see here. Along with Prof Bhaven Sampat, I am presenting a paper on innovation in India. Note the catchy title of the Conference: “The Dragon and the Elephant:Understanding the Development of Innovation Capacity In China and India”. I just wish that they’d used “tiger” instead of “elephant”:) 2. Workshop on ‘Trade and…


Read More »
Patent

Public Participation in IP Policy Making


Arun K Thiruvengadam, a brilliant constitutional law scholar who teaches at the National University of Singapore (NUS) comments on an interesting article in “law and other things” (where I co-blog as well). I reproduce his post below “The purpose of this post is to make a somewhat obvious and trite point, which, however, seems to be worth reiterating in current times. Kaushik Basu has a recent column in the HT which articulates this very well: “Democracy runs on participation, and…


Read More »

SPICY COMMENTS


We’re starting a new section, where we intend to pick up interesting comments by readers and post them on the blog. As many of you know, you can comment on any one of our posts by visiting the blog and clicking on the “comments” tab at the end of each post. Anyway, of the recent posts, we found the following to be the most interesting (“spicy”): 1. Shamnad’s post on JC Bose and his aversion to Patenting: Prof Rajesh Kochhar…


Read More »
Patent

SECTION 3(d) AND "EFFICACY": MORE CASES


1. Novartis abandons patent application in India: The business standard thinks that this could be prompted by fears of a Glivec type rejection and reports that: “Swiss pharma major Novartis has chosen not to pursue the patent application for its AIDS drug Atazanavir in India after the patent was declared “abandoned” even as it continues to fight for the licence rights of its cancer drug Glivec in the Indian patent office.” 2. Eli Lilly loses patent over osteoporosis drug: CH…


Read More »